Elizabeth Barrows
0000-0002-6082-3610
1 paper found
Refreshing results…
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
Missing publications? Search for publications with a matching author name.